Anuska Llano

1.9k total citations
47 papers, 853 citations indexed

About

Anuska Llano is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Anuska Llano has authored 47 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Virology, 25 papers in Immunology and 18 papers in Infectious Diseases. Recurrent topics in Anuska Llano's work include HIV Research and Treatment (41 papers), Immune Cell Function and Interaction (21 papers) and HIV/AIDS drug development and treatment (14 papers). Anuska Llano is often cited by papers focused on HIV Research and Treatment (41 papers), Immune Cell Function and Interaction (21 papers) and HIV/AIDS drug development and treatment (14 papers). Anuska Llano collaborates with scholars based in Spain, United States and Peru. Anuska Llano's co-authors include Bonaventura Clotet, José A. Esté, Christian Brander, Jordi Barretina, Julià Blanco, Beatriz Mothe, Arantxa Gutiérrez, Javier Ibarrondo, Cecilia Cabrera and Gemma Moncunill and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Anuska Llano

46 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anuska Llano Spain 19 561 424 286 217 118 47 853
María Rosa López‐Huertas Spain 21 655 1.2× 377 0.9× 505 1.8× 331 1.5× 244 2.1× 46 1.2k
Natalia Soriano-Sarabia United States 17 760 1.4× 555 1.3× 408 1.4× 144 0.7× 268 2.3× 42 1.1k
Nina Lin United States 15 645 1.1× 272 0.6× 457 1.6× 343 1.6× 180 1.5× 38 1.1k
H. C. Lane United States 13 438 0.8× 379 0.9× 319 1.1× 85 0.4× 252 2.1× 15 870
Alberto C. Guardo Spain 14 393 0.7× 406 1.0× 237 0.8× 241 1.1× 142 1.2× 31 794
Ming‐Bo Huang United States 17 405 0.7× 270 0.6× 226 0.8× 460 2.1× 116 1.0× 28 926
Sandrina DaFonseca Canada 16 937 1.7× 687 1.6× 495 1.7× 183 0.8× 253 2.1× 19 1.3k
M. Scott Killian United States 13 330 0.6× 439 1.0× 169 0.6× 123 0.6× 134 1.1× 27 776
Paul Bock United States 9 386 0.7× 329 0.8× 149 0.5× 106 0.5× 114 1.0× 9 778
Suha Saleh Australia 12 648 1.2× 379 0.9× 341 1.2× 261 1.2× 149 1.3× 22 927

Countries citing papers authored by Anuska Llano

Since Specialization
Citations

This map shows the geographic impact of Anuska Llano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anuska Llano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anuska Llano more than expected).

Fields of papers citing papers by Anuska Llano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anuska Llano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anuska Llano. The network helps show where Anuska Llano may publish in the future.

Co-authorship network of co-authors of Anuska Llano

This figure shows the co-authorship network connecting the top 25 collaborators of Anuska Llano. A scholar is included among the top collaborators of Anuska Llano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anuska Llano. Anuska Llano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bailón, Lucía, José Ramón Arribas, Adrián Curran, et al.. (2025). Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._. Communications Medicine. 6(1). 11–11.
2.
Prats, Anna, Anuska Llano, Cristina Gálvez, et al.. (2023). Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination. EBioMedicine. 95. 104732–104732. 3 indexed citations
3.
Llano, Anuska, Santiago Cedeño, Pep Coll, et al.. (2021). A placebo-controlled ati trial of HTI vaccines in early treated HIV infection. 29(1). 48–49. 5 indexed citations
4.
Berdasco, María, Anuska Llano, Beatriz Mothe, et al.. (2020). Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control. PLoS Pathogens. 16(8). e1008678–e1008678. 20 indexed citations
5.
Andrade, Viviane M., Carla Mavian, Dunja Z. Babič, et al.. (2020). A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption. Proceedings of the National Academy of Sciences. 117(18). 9981–9990. 45 indexed citations
6.
Olvera, Àlex, Anuska Llano, Beatriz Mothe, et al.. (2020). TL1A–DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1–Specific T Cell Responses. The Journal of Immunology. 205(12). 3348–3357. 3 indexed citations
7.
Rosás-Umbert, Míriam, Anuska Llano, Rocío Bellido, et al.. (2018). Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers. Journal of Virology. 93(4). 30 indexed citations
8.
Olvera, Àlex, Javier P. Martínez, María Casadellà, et al.. (2018). Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro. Frontiers in Immunology. 8. 2010–2010. 7 indexed citations
9.
Borthwick, Nicola, Tomohiro Akahoshi, Anuska Llano, et al.. (2017). Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines. PLoS ONE. 12(4). e0176418–e0176418. 26 indexed citations
10.
Ruiz‐Riol, Marta, Anuska Llano, Javier Ibarrondo, et al.. (2014). Alternative Effector-Function Profiling Identifies Broad HIV-Specific T-Cell Responses in Highly HIV-Exposed Individuals Who Remain Uninfected. The Journal of Infectious Diseases. 211(6). 936–946. 15 indexed citations
11.
Olvera, Àlex, Anuska Llano, Margherita Rosati, et al.. (2013). DNA-MVA Prime-Boost Vaccine Eliciting T-Cell Specificities Associated with HIV-1 Control Is Highly Immunogenic in Mice and Breaks CTL Immunodominance. AIDS Research and Human Retroviruses. 29. 1 indexed citations
12.
Fumaz, Carmina R., Marian González-García, Xavier Borràs, et al.. (2012). Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment. Brain Behavior and Immunity. 26(4). 568–572. 33 indexed citations
13.
Pernas, María, Concha Casado, Anuska Llano, et al.. (2012). Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller. PLoS ONE. 7(2). e31928–e31928. 20 indexed citations
14.
Moncunill, Gemma, Mercedes Armand‐Ugón, Imma Clotet‐Codina, et al.. (2008). Anti-HIV Activity and Resistance Profile of the CXC Chemokine Receptor 4 Antagonist POL3026. Molecular Pharmacology. 73(4). 1264–1273. 44 indexed citations
15.
Radi, Marco, Giovanni Maga, Alberta Samuele, et al.. (2008). Towards novel S-DABOC inhibitors: Synthesis, biological investigation, and molecular modeling studies. Bioorganic & Medicinal Chemistry Letters. 18(21). 5777–5780. 10 indexed citations
16.
Colobrán, Roger, Yaqoub Ashhab, Anuska Llano, et al.. (2005). Multiple Products Derived from Two CCL4 Loci: High Incidence of a New Polymorphism in HIV+ Patients. The Journal of Immunology. 174(9). 5655–5664. 38 indexed citations
17.
Moncunill, Gemma, Eugènia Negredo, Jaume Vilarrasa, et al.. (2005). Evaluation of the anti-HIV activity of statins. AIDS. 19(15). 1697–1700. 47 indexed citations
18.
Barretina, Jordi, Julià Blanco, Anna Bonjoch, et al.. (2004). Immunological and virological study of enfuvirtide-treated HIV-positive patients. AIDS. 18(12). 1673–1682. 27 indexed citations
19.
Barretina, Jordi, Jordi Juncà, Anuska Llano, et al.. (2003). CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease. Annals of Hematology. 82(8). 500–505. 56 indexed citations
20.
Llano, Anuska, et al.. (2001). CHARACTERISTICS OF NITRIC OXIDE-INDUCED APOPTOSIS AND ITS TARGET CELLS IN MITOGEN-STIMULATED PERIPHERAL BLOOD MONONUCLEAR CELLS FROM HIV+ SUBJECTS. Immunological Investigations. 30(4). 267–287. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Rosa López‐Huertas Breakdown of academic impact, for papers by Natalia Soriano-Sarabia Breakdown of academic impact, for papers by Nina Lin Breakdown of academic impact, for papers by H. C. Lane Breakdown of academic impact, for papers by Alberto C. Guardo Breakdown of academic impact, for papers by Ming‐Bo Huang Breakdown of academic impact, for papers by Sandrina DaFonseca Breakdown of academic impact, for papers by M. Scott Killian Breakdown of academic impact, for papers by Paul Bock Breakdown of academic impact, for papers by Suha Saleh
Rankless by CCL
2026